Grupo 29: Farmacología y Fisiopatología Vascular
Código de grupo: 7.29
Tipo de grupo: Consolidado
Descripción del grupo: Farmacología y fisiopatología vascular
Jefe de Grupo: Francisco Pérez Vizcaíno
Integrantes del grupo | |
---|---|
Investigadores y personal de apoyo |
BARON | ARGOS | LOURDES | |||
BARREIRA | BARBA | BIANCA | Other | ||
CARRIÓN | MARCHANTE | REBECA | |||
COGOLLUDO | TORRALBA | ÁNGEL | Established Researcher | ||
DA COSTA | ADAO | RUI MIGUEL | Recognised Researcher | ||
GIMENO | LONGAS | MARÍA JOSÉ | Recognised Researcher | ||
MORALES | CANO | DANIEL | Recognised Researcher | ||
MORENO | GUTIERREZ | LAURA | Established Researcher | ||
OLIVENCIA | PLAZA | MIGUEL ÁNGEL | First Stage Researcher | ||
PÉREZ | VIZCAÍNO | FRANCISCO | Leading Researcher | ||
SANCHO | GONZÁLEZ | MARÍA | Recognised Researcher | ||
VILLEGAS | ESGUEVILLAS | MARTA | First Stage Researcher |
Líneas de investigación | |
---|---|
Axis 1. Pulmonary Hypertension
L1: Pulmonary vascular dysfunction in pulmonary hypertension (PH). L2: Role of vitamin D and the microbiota in pulmonary hypertension (PH). L3: Role of TASK1 and Kv7 potassium channels in pulmonary hypertension. L4: Role of mutations in the KCNA5 gene in pulmonary hypertension patients. L5: Liver-lung axis. How liver exosomes from healthy and cirrhotic animals influence the lung. Axis 2. Erectile dysfunction L1: Role of vitamin D and microbiota in erectile dysfunction. Axis 3. Acute lung damage L1: Acute Respiratory Distress Syndrome (ARDS). L2: Bronchodysplasia of the lung (BDP). |
First decile publications | 1 | 7,0 |
First quartile publications | 3 | 22,2 |
Second quartile publications | 1 | 6,0 |
Third quartile publications | 0 | 0,0 |
Total publications (including those without IF) | 4 | 28,2 |